Loading clinical trials...
Loading clinical trials...
A Multi-Center, Randomized, Double-Masked, Placebo-Controlled Evaluation of the Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens as Compared to Placebo in the Prevention of Allergic Conjunctivitis in a Population of Allergic Contact Lens Wearers
The purpose of this study is to evaluate the efficacy and safety of an anti-allergy drug with a contact lens compared to placebo in preventing ocular itching associated with allergic conjunctivitis
Age
8 - No limit years
Sex
ALL
Healthy Volunteers
No
Phoenix, Arizona, United States
Phoenix, Arizona, United States
Irvine, California, United States
North Andover, Massachusetts, United States
Cincinnati, Ohio, United States
Fairfield, Ohio, United States
Mason, Ohio, United States
Start Date
February 1, 2007
Completion Date
May 1, 2007
Last Updated
April 9, 2009
120
ESTIMATED participants
Ketotifen with a Contact Lens (no generic name)
DRUG
Lead Sponsor
Vistakon Pharmaceuticals
NCT05839938
NCT05186025
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT05191186